By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TetraLogic Pharmaceuticals 

365 Phoenixville Pike

Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-889-9900 Fax: 610-889-9994



Start Up

Company News
TetraLogic (TLOG) Announces Completion Of Sale Of SMAC Mimetic And HDAC Inhibitor Assets To Medivir (MVRBF) 12/29/2016 10:42:24 AM
TetraLogic (TLOG) Announces Agreements To Sell SMAC Mimetic And HDAC Inhibitor Assets To Medivir (MVRBF) And To Restructure Its Convertible Senior Notes And Delisting Of Common Stock 11/3/2016 10:59:19 AM
TetraLogic (TLOG) Slashes Two-Thirds of Workforce After Mid-Stage Trial Failure 1/22/2016 2:44:38 PM
TetraLogic Pharmaceuticals (TLOG) Announces Clinical Data On Birinapant To Be Presented At The 57th Annual American Society of Hematology Annual Meeting 11/9/2015 10:22:46 AM
TetraLogic Pharmaceuticals (TLOG) Announces The Opening Of An IND For SHAPE Gel In Alopecia Areata 11/2/2015 7:41:42 AM
TetraLogic Pharmaceuticals (TLOG) To Present At The Jefferies and Co. 2015 Hepatitis B Summit 7/29/2015 8:13:55 AM
TetraLogic Pharmaceuticals (TLOG) Provides Update On Hepatitis B Clinical Program 7/21/2015 7:20:12 AM
TetraLogic Pharmaceuticals (TLOG) Announces Update On MDS Clinical Program 7/1/2015 7:26:24 AM
TetraLogic Pharmaceuticals (TLOG) Announces Termination Of Public Offering 5/6/2015 11:03:31 AM
TetraLogic Pharmaceuticals (TLOG)’s New IPO Takes A Hit As Company Halts Hepatitis B Trial 5/6/2015 8:29:35 AM